Healthy Skepticism Library item: 11946
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Sipkoff M.
Rebates for anti-anemia drugs draw response from FDA, CMS.
Manag Care 2007 Jun; 16:(6):17-8
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17682732
Abstract:
No abstract available
Keywords:
MeSH Terms:
Anemia/drug therapy*
Anemia/etiology
Conflict of Interest
Drug Industry/economics*
Epoetin Alfa/administration & dosage
Epoetin Alfa/adverse effects
Epoetin Alfa/economics*
Epoetin Alfa/therapeutic use*
Erythropoietin/administration & dosage
Erythropoietin/adverse effects
Erythropoietin/analogs & derivatives*
Erythropoietin/economics
Erythropoietin/therapeutic use
Hematinics/administration & dosage
Hematinics/adverse effects
Hematinics/economics*
Hematinics/therapeutic use*
Humans
Kidney Failure, Chronic/complications
Medical Oncology/economics*
Medicare
Neoplasms/complications
Nephrology/economics*
Product Surveillance, Postmarketing
United States
United States Centers for Medicare and Medicaid Services
United States Food and Drug Administration
Substances:
Hematinics
Erythropoietin
Epoetin Alfa
darbepoetin alfa
